Changes in Stress, Substance Use and Medication Beliefs are Associated with Changes in Adherence to HIV Antiretroviral Therapy

被引:17
作者
French, Tyler [1 ]
Tesoriero, James [1 ]
Agins, Bruce [2 ]
机构
[1] New York State Dept Hlth, AIDS Inst, Off Program Evaluat & Res, Albany, NY 12204 USA
[2] New York State Dept Hlth, Off Med Director, AIDS Inst, New York, NY 10007 USA
关键词
Treatment adherence; Antiretroviral therapy; ARV; HIV; AIDS; Predictors; Longitudinal study; PROTEASE INHIBITOR THERAPY; SELF-REPORTED ADHERENCE; ILLICIT DRUG-USE; PSYCHIATRIC-DISORDERS; LONGITUDINAL ANALYSIS; INFECTED ADULTS; HEALTH BELIEFS; PREDICTORS; NONADHERENCE; DEPRESSION;
D O I
10.1007/s10461-010-9762-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Stress, substance use and medication beliefs are among the most frequently cited barriers to HIV treatment adherence. This study used longitudinal techniques to examine the temporal relationship between these barriers and adherence among clients attending treatment adherence support programs in New York State. A total of 4,155 interview pairs were analyzed across three interview transitions. Multinomial models were constructed with four-category change-based independent variables (e. g., low stress at both interviews, low stress at interview 1 and high stress at interview 2, high stress at interview 1 and low stress at interview 2, high stress at both interviews) that predicted a similarly constructed four-category adherence change variable. Clients who reported positive changes in stress, substance use, or medication beliefs were more likely to change from being nonadherent to being adherent, while clients who reported negative changes were more likely to change from being adherent to being nonadherent. To improve or maintain adherence over time, strategies should be used that facilitate positive changes-and prevent negative changes-in stress, substance use, and medication beliefs.
引用
收藏
页码:1416 / 1428
页数:13
相关论文
共 54 条
[1]   Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature [J].
Ammassari, A ;
Trotta, MP ;
Murri, R ;
Castelli, F ;
Narciso, P ;
Noto, P ;
Vecchiet, J ;
D'Arminio Monforte, A ;
Wu, AW ;
Antinori, A .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S123-S127
[2]   Management of psychiatric disorders in patients infected with human immunodeficiency virus [J].
Angelino, AF ;
Treisman, GJ .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (06) :847-856
[3]   Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users [J].
Arnsten, JH ;
Demas, PA ;
Grant, RW ;
Gourevitch, MN ;
Farzodegan, H ;
Howard, AA ;
Schoenboum, EE .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (05) :377-381
[4]   Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression [J].
Bangsberg, David R. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) :939-941
[5]   Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[6]   Non-adherence to highly active antiretroviral therapy predicts progression to AIDS [J].
Bangsberg, DR ;
Perry, S ;
Charlebois, ED ;
Clark, RA ;
Roberston, M ;
Zolopa, AR ;
Moss, A .
AIDS, 2001, 15 (09) :1181-1183
[7]   Age-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status [J].
Barclay, Terry R. ;
Hinkin, Charles H. ;
Castellon, Steven A. ;
Mason, Karen I. ;
Reinhard, Matthew J. ;
Marion, Sarah D. ;
Levine, Andrew J. ;
Durvasula, Ramani S. .
HEALTH PSYCHOLOGY, 2007, 26 (01) :40-49
[8]   Major depression in patients with HIV/AIDS and substance abuse [J].
Berger-Greenstein, Jori A. ;
Cuevas, Carlos A. ;
Brady, Stephen M. ;
Trezza, Glenn ;
Richardson, Mark A. ;
Keane, Terence M. .
AIDS PATIENT CARE AND STDS, 2007, 21 (12) :942-955
[9]   Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States [J].
Bing, EG ;
Burnam, A ;
Longshore, D ;
Fleishman, JA ;
Sherbourne, CD ;
London, AS ;
Turner, BJ ;
Eggan, F ;
Beckman, R ;
Vitiello, B ;
Morton, SC ;
Orlando, M ;
Bozzette, SA ;
Ortiz-Barron, L ;
Shapiro, M .
ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (08) :721-728
[10]  
Carrieri P, 2001, J ACQ IMMUN DEF SYND, V28, P232, DOI 10.1097/00042560-200111010-00005